Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sequent Scientific has informed that the Company has, as a part of its investors engagement activities, scheduled a conference call with the Analysts / Investors on Thursday, May 16, 2024, to discuss its Q4 FY24 financial results. The Conference call details are enclosed.
The above information is a part of company’s filings submitted to BSE.